Can influenza A increase the risk of developing pulmonary emboli?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Influenza A and Pulmonary Embolism Risk

Yes, influenza A infection can increase the risk of developing pulmonary emboli, particularly in severe cases, though the association is not consistently observed across all studies.

Pathophysiological Relationship Between Influenza and Thromboembolism

Influenza infections, particularly severe cases, can create conditions favorable for thromboembolic events through several mechanisms:

  • Inflammatory Response: Severe influenza can trigger a significant inflammatory response that may promote a hypercoagulable state
  • Endothelial Damage: Viral infection can damage the vascular endothelium, potentially initiating the coagulation cascade
  • Immobilization: Severe illness often leads to reduced mobility, a known risk factor for venous thromboembolism

Evidence for the Association

The evidence regarding the relationship between influenza A and pulmonary embolism is mixed:

Supporting Evidence

  • A scoping review found that among 58 cases of thromboembolic events associated with laboratory-confirmed influenza, pulmonary embolism was the most common manifestation (36.2% of cases) 1

  • Case reports have documented acute pulmonary microthromboembolism in patients with influenza A(H3N2) virus infection who presented with rapidly progressive hypoxemia 2

  • A case series of patients with H1N1 influenza found that 6 out of 7 patients developed pulmonary embolism without deep vein thrombosis while hospitalized for influenza pneumonia 3

  • Individual case reports have documented concurrent thrombotic events including pulmonary embolism in patients with influenza-associated pneumonia 4

Contradictory Evidence

  • A nested case-control study did not find an association between influenza infection and increased risk of acute pulmonary embolism. In fact, the percentage of patients with influenza A was higher in the control group compared to patients with confirmed pulmonary embolism (4.3% versus 1.0%) 5

Clinical Implications

High-Risk Populations

Certain groups may be at higher risk for complications including thromboembolic events:

  • Elderly patients
  • Patients with underlying cardiopulmonary disease
  • Immunocompromised individuals
  • Pregnant women
  • People with diabetes

Diagnostic Challenges

Symptoms of pulmonary embolism can overlap with those of severe influenza, making diagnosis challenging:

  • Both conditions can present with dyspnea, hypoxemia, and respiratory distress
  • Careful clinical evaluation is essential, as highlighted in the scoping review 1

Management Considerations

For patients with severe influenza, especially those with risk factors for thromboembolism:

  • Consider thromboprophylaxis in hospitalized patients with severe influenza
  • Maintain high clinical suspicion for pulmonary embolism in patients with unexplained or disproportionate dyspnea
  • Appropriate diagnostic workup may include D-dimer testing, ventilation-perfusion scanning, or CT pulmonary angiography in suspected cases

Conclusion

While not all studies show a consistent association, there is evidence suggesting that influenza A infection, particularly severe cases requiring hospitalization, may increase the risk of pulmonary embolism. Clinicians should maintain vigilance for thromboembolic complications in patients with severe influenza, especially when respiratory symptoms worsen unexpectedly or are disproportionate to the degree of pulmonary involvement seen on imaging.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.